ANTI-TUMOR EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-1 IN MICE TRANSPLANTED WITH DIFFERENT SYNGENEIC TUMORS

被引：33

作者：

BELARDELLI, F

CIOLLI, V

TESTA, U

MONTESORO, E

BULGARINI, D

PROIETTI, E

BORGHI, P

SESTILI, P

LOCARDI, C

PESCHLE, C

GRESSER, I

机构：

[1] IST SUPER SANITA,DEPT HEMATOL & ONCOL,I-00161 ROME,ITALY

[2] INST RECH SCI CANC,VIRAL ONCOL LAB,F-94802 VILLEJUIF,FRANCE

来源：

INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 06期

关键词：

D O I：

10.1002/ijc.2910440629

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1108 / 1116

页数：9

共 37 条

[11] ANTITUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .5. COMPARISONS WITH THE ACTION OF TUMOR-NECROSIS-FACTOR
GRESSER, I
BELARDELLI, F
TAVERNIER, J
FIERS, W
PODO, F
FEDERICO, M
CARPINELLI, G
DUVILLARD, P
PRADE, M
MAURY, C
BANDU, MT
MAUNOURY, MT
[J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) : 771 - 778
[12] EFFECTIVENESS OF MOUSE INTERFERON ALPHA-BETA-COMPARED TO SINGLE-AGENT CHEMOTHERAPY IN INCREASING SURVIVAL-TIME OF MICE AFTER INTRAVENOUS INOCULATION OF FRIEND-ERYTHROLEUKEMIA CELLS
GRESSER, I
MAURY, C
BELARDELLI, F
MAUNOURY, MT
MACHOVER, D
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (02) : 126 - 131
[13] INJECTION OF MICE WITH ANTIBODY TO INTERFERON ENHANCES THE GROWTH OF TRANSPLANTABLE MURINE TUMORS
GRESSER, I
BELARDELLI, F
MAURY, C
MAUNOURY, MT
TOVEY, MG
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) : 2095 - 2107
[14] ANTITUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .6. ADJUVANT THERAPY AFTER SURGERY IN THE INHIBITION OF LIVER AND SPLEEN METASTASES
GRESSER, I
MAURY, C
BELARDELLI, F
[J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (06) : 789 - 792
[15] INTERFERON TREATMENT MARKEDLY INHIBITS THE DEVELOPMENT OF TUMOR-METASTASES IN THE LIVER AND SPLEEN AND INCREASES SURVIVAL-TIME OF MICE AFTER INTRAVENOUS INOCULATION OF FRIEND-ERYTHROLEUKEMIA CELLS
GRESSER, I
MAURY, C
WOODROW, D
MOSS, J
GRUTTER, MG
VIGNAUX, F
BELARDELLI, F
MAUNOURY, MT
[J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) : 135 - 142
[16] KAYE J, 1984, J IMMUNOL, V133, P1339
[17] LAFRENIERE R, 1985, J IMMUNOL, V135, P4273
[18] LAFRENIERE R, 1985, CANCER RES, V45, P3735
[19] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS
LOTZE, MT
CHANG, AE
SEIPP, CA
SIMPSON, C
VETTO, JT
ROSENBERG, SA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22): : 3117 - 3124
[20] HUMAN INTERLEUKIN-2 - MOLECULAR-BIOLOGY, PHYSIOLOGY AND CLINICAL POSSIBILITIES
MERTELSMANN, R
WELTE, K
[J]. IMMUNOBIOLOGY, 1986, 172 (3-5) : 400 - 419

← 1 2 3 4 →